Study
A narrative review discussing how the gut–brain axis impacts anxiety and depression.
In plain language
A narrative review discussing how the gut–brain axis impacts anxiety and depression. The authors describe mechanisms involving neurotransmitters and inflammation, and summarize evidence for probiotics, diet, and microbiota-based therapies as emerging management tools.
Use the full description to understand the study design, methods, and the limits of the findings.
This review explores the emerging evidence linking gut microbiome composition to anxiety and depression. The research examines bidirectional gut-brain communication pathways and how microbiota-targeted interventions might offer novel approaches to mental health treatment.
Open the original publication for the complete methods, outcomes, and source material.
Published November 2025
Opens at the publisher · external site · may require institutional access
The study provides a comprehensive overview of the gut-brain axis in relation to anxiety and depression. While it effectively synthesizes existing research, its narrative review format limits its methodological rigor compared to systematic reviews. The study is transparent and relevant, with appropriate conflict of interest disclosures.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 6.7/10 | |
| Bias & Methods | 6.7/10 | |
| Statistical Integrity | 5.0/10 | |
| Transparency | 10.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 7.5/10 |
The study could be strengthened by including a more systematic approach to literature selection and bias assessment. Future research could benefit from empirical studies to validate the discussed mechanisms and interventions.
Build a personalized plan using research-backed studies, conditions, and treatments.